The effect of volatile 1-cyclohexyl-2-methylaminopropane ("Benzedrex" inhaler) on patients with coronary arteriosclerosis.
D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D003324:Coronary Artery Disease; D003327:Coronary Disease / Q000628:therapy*; D004232:Diuretics; D006801:Humans; D009330:Nebulizers and Vaporizers; D011437:Propylamines; D013566:Sympathomimetics / Q000627:therapeutic use*
D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D004232:Diuretics; D011437:Propylamines; D013566:Sympathomimetics; C084814:propylhexedrine
CORONARY DISEASE/therapy; SYMPATHOMIMETICS/therapeutic use